The present invention provides an .alpha.-2A/.alpha.-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, stereoisomer or racemic mixture thereof. The present invention further provides a pharmaceutical composition that contains a pharmaceutical carrier and a therapeutically effective amount of an .alpha.-2A/.alpha.-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, stereoisomer or racemic mixture thereof.

 
Web www.patentalert.com

< CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL

> METHOD OF TREATING ORGANISM BY BIOLOGICALLY ACTIVE COMPOUNDS SPECIFICALLY DELIVERED INTO MITOCHONDRIA, PHARMACEUTICAL COMPOSITION REQUIRED FOR THE USE OF THE METHOD AND A COMPOUND APPLICABLE FOR THIS PURPOSE

~ 00450